References of "Gillard, Patricia"
     in
Bookmark and Share    
Full Text
Peer Reviewed
See detailScedosporium apiospermum septicemia following a wedge excision of an ingrown toenail.
Vanhooteghem, Olivier ULg; Gillard, Patricia ULg; Dezfoulian, Bita ULg et al

in International Journal of Dermatology (2009), 48(10), 1137-1139

Detailed reference viewed: 12 (0 ULg)
Full Text
Peer Reviewed
See detailEtanercept in Therapy Multiresistant Pityriasis Lichenoides, overlapping type
Nikkels, Arjen ULg; Gillard, Patricia ULg; Pierard, Gérald ULg

in Journal of Drugs in Dermatology (2008)

Introduction : Pityriasis licehnoides (PL) exhibits a protean clinical presentation, particularly in its overlapping form (OPL) combining aspects of the acute and chronic types. Some patients are drug ... [more ▼]

Introduction : Pityriasis licehnoides (PL) exhibits a protean clinical presentation, particularly in its overlapping form (OPL) combining aspects of the acute and chronic types. Some patients are drug multiresistant and pose a therapeutic dilemma. The anti-tumor necrosis factor (TNF)-α agent etanercept, was recently introduced as an alternative treatment for psoriasis, rheumatoid arthritis, and psoriatic arthritis. Case Report: A 65-year-old woman suffered from an overlapping form of pityriasis lichenoides (OPL) for 5 years. Several initial acute episodes were controlled by successive courses of oral antibiotics, topical corticosteroids, and/or psoralen ultraviolet light-A (PUVA) therapy. The disease progressively evolved to a more chronic form. Topical immune response modifiers and corticosteroïds, as well as PUVA, ultraviolet light B (UVB), methorexate, dapsone, and cyclosporine were introduces, but all proved ineffective. Due to the therapy multiresistance, 2 weekly injections of etanercept were administered. After 2 months, a marked improvement was observed in regards to the patient’s pruritus and inflammation. No treatment-related adverse effects were observed. Therapy was continued for 4 months without any new lesion development. However, 1 month after stopping treatment new OPL lesions recurred. Conclusion : At the time of publication, this is the first report of the effectiveness of etanercept in OPL. This drug might be considered as a therapeutic alternative for treatment multiresistant OPL. [less ▲]

Detailed reference viewed: 83 (9 ULg)
Full Text
Peer Reviewed
See detailLe lichen sclereux vulvaire
Gillard, Patricia ULg; Vanhooteghem, Olivier ULg; Richert, Bertrand ULg et al

in Revue Médicale de Liège (2005), 60(7-8), 656-660

Vulvar lichen sclerosus is a frequent mucocutaneous disease especially affecting 50 to 60 year-old women but with a possible onset at very young age. Symptoms are most disabling including pruritus and ... [more ▼]

Vulvar lichen sclerosus is a frequent mucocutaneous disease especially affecting 50 to 60 year-old women but with a possible onset at very young age. Symptoms are most disabling including pruritus and dyspareunia. Vulvar mucosa gradually becomes more white and atrophied. Degeneration into epidermoid carcinoma is possible. Treatment only consists of topical corticosteroids. [less ▲]

Detailed reference viewed: 166 (4 ULg)
Peer Reviewed
See detailCharacterisation of a novel topical nanoemulsion vehicle with spreading properties
Roland, Isabelle ULg; Gillard, Patricia ULg; Delattre, Luc ULg et al

in Proceedings of Eur conference on drug delivery and pharmaceutical technology (2004)

Detailed reference viewed: 29 (1 ULg)